Topic

#psilocybin

2 stories

Health

15 Oct 2026

Compass Pathways Prepares Psilocybin Therapy for FDA Review

Compass Pathways CEO warns a cautious rollout to protect the emerging psychedelic field as the company finalizes its FDA submission for COMP360.

Health

15 Oct 2026

Low‑dose LSD alters how people see, but not contrast perception

Very small doses of LSD can make colors feel richer and vision a little blurrier, yet they do not change a common visual illusion that depends on surrounding context.